Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arbaclofen for Social Function in ASD
NCT03682978Phase 2Completed
- Start
- Sep 2019
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of arbaclofen in Autism Spectrum Disorder (ASD). Started Sep 2019; status: completed.
02
Drugs
arbaclofen
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03682978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03682978.